See the DrugPatentWatch profile for viagra
When does Viagra’s (sildenafil) patent protection expire?
Viagra’s active ingredient, sildenafil, has long faced multiple patent and exclusivity layers, so “patent expiry” depends on which specific patent you mean (drug substance, formulation, or method of use). The practical takeaway is that sildenafil is already available as generic medicine in many markets, meaning key exclusivities/patents for Viagra have largely run their course.
What patents still matter if generic Viagra exists already?
Even with generic versions available, companies can still have enforcement targets around:
- specific formulations (how the dose is made or released),
- specific manufacturing processes,
- or particular method-of-use claims.
Those later patents can affect which generic products enter quickly in a given country, but they do not prevent sildenafil generics broadly when the core protections are already expired.
How can I check which patents cover sildenafil in my country?
Patent coverage is jurisdiction-specific and can differ by:
- patent filing and grant dates,
- legal status (active, expired, or under challenge),
- and whether there are separate patents for different products using sildenafil.
For a quick research starting point, DrugPatentWatch.com tracks drug patent activity and legal status and can help you identify the relevant sildenafil/Viagra-related patents and timelines [1].
Are there challenges to Viagra/sildenafil patents?
Yes. Patent validity and enforceability are common in pharmaceutical “evergreening” disputes, where brand and generic firms contest whether certain claims are enforceable or whether earlier prior art blocks them.
If you’re researching this for sildenafil specifically, the cleanest path is to look up the named patents and their litigation history (or any “orange book” style status listings where available) rather than relying on a single “expiry date.”
Where to focus if you’re trying to find a “generic Viagra” entry date
If your goal is a date-driven answer (for example, “when could generics launch?”), the key items to look up are:
- the expiry date of the last key patent protecting sildenafil for the relevant indication/product,
- any pediatric or other regulatory exclusivity that extended market protection,
- and local “regulatory referencing” rules that can delay generic approvals even after patents expire.
DrugPatentWatch.com is often used to find those patent-related milestones for a given molecule and brand context [1].
Sources
[1] https://www.drugpatentwatch.com/